investor relations
profile
GenPhar is a biopharmaceutical company that develops innovative prophylactic and therapeutic products to improve the treatment of viral diseases. Each of our vaccines and therapies has a wide range of applications for multiple viral agents.
GenPhar’s strength lies in our ability to leverage the company’s unique and flexible technology platforms to create multiple products with significant market potential.
GenPhar's global health and biodefense vaccine product timelines can be found here
GenPhar is currently seeking partnerships and new investments for advanced development and production of vaccines for biodefense and the global market.
print this page
contact us
site map